BigHat Biosciences — AI platform for designing antibody therapeutics
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
Get it by email
Companies like BigHat Biosciences go out every weekday morning. One-click unsubscribe.
- Round
- $75M Series C
- Sectors
- Biotechnology
- Logged
- September 26, 2026, in issue #39
- Website
- www.bighatbio.com
More in biotechnology

$4.7M Seed · getpeppermint.ai
Peppermint — Billing and collections for clinical trial sites
Peppermint is a software company based in San Francisco that focuses on AI-powered financial operations for clinical research teams. It aims to modernize the financial infrastructure used by hospital systems and research sites to manage clinical trials. Founded in 2026, the company provides a platform that automates billing, invoicing, and collections. This platform integrates with existing clinical trial management systems to streamline revenue cycle management.
BiotechnologySoftwareHealthcareEvan MooreBenjamin MannNight Capital · +8 · +11
$16.4M · vescent.com
Vescent Technologies — Frequency combs, lasers and controls for quantum tech
Vescent is leading and enabling the commercialization of Quantum Technologies in the lab and in the field. It has been providing frequency Combs, Lasers, and Controls to 100s of customers on the front lines of scaling the commercial quantum ecosystem throughout the world with low-SWaP, ruggedness, and IP.
ManufacturingBiotechnology$10M+
$75M · happysleep.com
Happy Health — Smart ring that diagnoses sleep apnea at home
Happy Health is a Texas-based digital health company developing a physician-guided platform for continuous home healthcare. The company has created an FDA-cleared smart ring that diagnoses obstructive sleep apnea in as few as three nights using clinical-grade sensors and AI-powered physiological modeling. By collecting over 2.8 million biometric measurements nightly, Happy Health's platform builds individualized physiological baselines to detect disease earlier and shift care delivery from hospitals to homes. The platform aims to eventually support detection and management across cardiovascular, metabolic, and other chronic diseases.
BiotechnologyHealthcareArtificial intelligenceArch Venture PartnersOpenLoop$50M+ · +1 · +4